NCT03156790 PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia Status TERMINATED Phase PHASE2
NCT03119662 A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease Status TERMINATED Phase PHASE4
NCT03093870 Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT03051256 Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD Status COMPLETED Phase PHASE2
NCT03032419 Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months Status COMPLETED Phase PHASE3
NCT02947685 Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02935790 Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab Status COMPLETED Phase PHASE1
NCT02914353 Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02880865 Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Status COMPLETED Phase PHASE4
NCT02859909 This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT02851797 Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE3
NCT02849951 A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) Status TERMINATED Phase PHASE3
NCT02827630 Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes Status COMPLETED Phase NA
NCT02810444 Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID Status COMPLETED Phase PHASE3
NCT02807363 A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers Status COMPLETED Phase PHASE2
NCT02722278 A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Status COMPLETED Phase PHASE3
NCT02636036 Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors Status COMPLETED Phase PHASE1
NCT02588105 Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02508740 Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment Status TERMINATED Phase PHASE1